Commonwealth Equity Services’s iBio IBIO Stock Holding History

Commonwealth Equity Services’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-101	Closed	-$77K	–	3552
2021 Q1	$77K	Buy	+101	New	+$88K	﹤0.01%	3303

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Commonwealth Equity Services's IBIO Position: Q2 2021 in Review

Commonwealth Equity Services sold out of iBio (IBIO) in Q2 2021, closing a stake of 101 shares — an estimated $77K sold.

Commonwealth Equity Services first reported a position in IBIO in Q1 2021 and held it in 1 quarter. The position peaked at $77K in Q1 2021. 83 funds tracked by Wall St. Rank hold IBIO as of Q2 2021.

Commonwealth Equity Services reported no remaining iBio position as of Q2 2021 after selling out during the quarter.
Commonwealth Equity Services sold 101 iBio shares in Q2 2021, an estimated $77K.
Commonwealth Equity Services first reported a position in iBio in Q1 2021 and held it in 1 quarter.
Commonwealth Equity Services's iBio position peaked at $77K in Q1 2021.
83 funds tracked by Wall St. Rank held iBio as of Q2 2021.

Based on Commonwealth Equity Services's 13F filing for Q2 2021, filed 11 Aug 2021.